Embody
acquired by ZimmerVienna, US · Founded 2017 · Virginia corporation · 1 known investors
Developer of biointegrative soft tissue regeneration solutions for orthopedic injuries; acquired by Zimmer Biomet in 2023.
Biotech
Founders & leadership
MF
Michael FrancisDirector
JC
Jeffrey ConroyChief Executive Officer
TM
Tim MeyersDirector
MO
Michael O'KaneDirector
RB
Rob BallDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$10.4MraisedOct 2022 · 94 investors · BiotechnologyRule 506(b)
▶$10.4MraisedOct 2022 · 94 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey ConroyExecutive Officer, Director
- Offering amount
- $12M
- Amount sold
- $10.4M
- First sale
- Jul 2022
- Incorporated
- Corporation, Virginia, 2018
- Federal exemptions
- 06b
▶$10.5MraisedJul 2021 · 65 investors · BiotechnologyRule 506(b)
▶$10.5MraisedJul 2021 · 65 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey ConroyExecutive Officer, Director
- Offering amount
- $12M
- Amount sold
- $10.5M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$9.3MraisedApr 2020 · 50 investors · BiotechnologyRule 506(b)
▶$9.3MraisedApr 2020 · 50 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael FrancisDirector
- Jeffrey ConroyExecutive Officer, Director
- Tim MeyersDirector
- Rob BallDirector
- Michael O'KaneDirector
- Offering amount
- $9.3M
- Amount sold
- $9.3M
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.